February 28, 2011
Prepared by the SaneVax Team
SaneVax Analysis of VAERS Reports Post-HPV Vaccination
The SaneVax Team is working to prepare symptom-specific analyses of adverse events experienced after HPV vaccination with Gardasil® and Cervarix®, the currently FDA approved vaccines being marketed as cervical cancer prevention measures. All information in these reports comes directly from VAERS, the vaccine adverse event reporting system in the United States.
SaneVax Inc. is well aware of the limitations to the VAERS system. Not all adverse events are reported. The best estimates to date indicate only 1-10% of adverse events are actually filed in the system. Because VAERS is a voluntary system, and anyone can report an injury, there may be duplicate and/or heresay reports. Nevertheless, the system is the best we have to work with.